| Course | PHE 321 Biological Concepts for Public Health |
|---|---|
| Module | Module 3 |
| Paper type | undergraduate short paper on host response and the course of chronic infection |
| Length | About 1,040 words, 6 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | BS Public Health |
| Updated | October 2026 |
Free sample paper for PHE 321 Module 3
Decades of Quiet: The Host Response to Trypanosoma cruzi and Why Timing Shapes Public Health Action
[Student Name]
Southern New Hampshire University
PHE 321: Biological Concepts for Public Health
Module Three Short Paper
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Decades of Quiet: The Host Response to Trypanosoma cruzi and Why Timing Shapes Public Health Action
Most people infected with Trypanosoma cruzi do not know it, and many never will. A smaller group develops heart failure, dangerous heart rhythms or digestive disease years or decades after infection. The difference between these outcomes lies largely in the relationship between the parasite and the host's defenses. This paper explains that relationship for a public health district in South Texas: what happens in the first weeks of infection, why the immune system controls but rarely eliminates the parasite, how damage builds over time in some people and what the timeline means for public health.
The Acute Phase
After the parasite enters the body, it invades cells near the entry site and then spreads through the blood to many tissues. For several weeks, parasites can be seen in the blood under a microscope. Rassi et al. (2010) describe this acute phase as usually mild or without symptoms. Some people have fever, swollen lymph nodes or swelling at the entry site, such as a swollen eyelid when bug feces entered through the eye. Severe acute disease, such as inflammation of the heart muscle or brain, is uncommon and occurs mainly in young children or people with weakened immunity. Because symptoms are usually absent or resemble a common viral illness, acute infections are rarely diagnosed outside regions where clinicians expect them.
The Immune Truce
Within weeks to months, the immune system brings parasite numbers down sharply. Antibodies and immune cells, especially cells that recognize and destroy infected cells, reduce parasites in the blood to levels too low to see. This control has two important consequences. First, the person feels well and may never seek care. Second, antibodies remain detectable for life, which is why chronic infection is diagnosed through blood tests for antibodies rather than by finding the parasite itself. The parasite is not eliminated, however. Small numbers persist in tissues, particularly in heart muscle and the smooth muscle of the digestive tract, held in check by ongoing immune activity. This long period without symptoms, called the indeterminate form, can last a lifetime.
How Damage Builds
In a minority of chronically infected people, the balance gives way to damage. Rassi et al. (2010) estimate that 30% to 40% of infected people in Latin America have or will develop heart disease, digestive enlargement of the esophagus or colon, or both. The current understanding is that persistent parasites in tissue drive continuing inflammation, and that inflammation, together with damage to the small nerves that regulate the heart and gut, slowly scars muscle. In the heart, this can cause enlargement, weakened pumping, rhythm disturbances and sudden death. In the digestive tract, nerve loss can leave the esophagus or colon unable to move food normally. Why some people progress and others do not is not fully understood; parasite strain, the amount of parasite in tissue, the host's genetic makeup and the strength and type of immune response all appear to play a part.
Special Hosts
Some hosts face different risks. In people whose immune systems are weakened, for example by organ transplant drugs or advanced HIV, the truce can break down and the infection can reactivate, sometimes severely. Pregnancy matters for a different reason: parasites in the mother's blood can cross the placenta. Howard et al. (2014) estimated that roughly one in twenty babies born to infected mothers is infected. Most infected newborns have no symptoms, but treatment in infancy is highly effective, which makes newborn testing of babies born to infected mothers especially valuable. Bern et al. (2011) note that because most U.S. infections occur in immigrants from endemic areas, infected women of childbearing age are an important group for prevention.
Treatment and Timing
Two drugs, benznidazole and nifurtimox, can kill the parasite. Rassi et al. (2010) describe treatment as reasonably safe and effective and note that it is recommended for a widening range of patients. Treatment works best early: in acute and congenital infection and in children it often cures, while in adults with long-standing infection its effect on preventing heart disease is less certain, though treating women before pregnancy reduces the chance of passing the infection to their babies. This makes timing central. Finding infection early, before damage builds, offers the most benefit.
What Remains Uncertain
Honest public health planning has to acknowledge what science has not settled. Researchers still debate how much of the heart damage comes from the parasite itself and how much from the body's own immune attack on heart tissue, and the answer affects whether killing the parasite late in life can halt the disease. Clinical trials in adults who already have heart damage have not shown clear benefit from antiparasitic treatment, which is why recommendations for older adults vary. There is no vaccine, and none is close. Tests also have limits: no single antibody test is accurate enough on its own, so diagnosis requires two different tests that agree. These uncertainties do not weaken the case for finding infected people. They shift the emphasis toward groups where the benefit is clearest, children, women before or during pregnancy and newborns, while offering adults evaluation and an informed discussion of treatment.
What the Timeline Means for the District
The host response explains why Chagas disease is invisible in routine care and why public health must go looking for it. Antibody testing is the right tool because the immune system leaves a lifelong mark. The people who gain most from being found are children, women of childbearing age and anyone about to receive immune-suppressing treatment. Adults with long-standing infection still benefit from a baseline heart evaluation, because early recognition of rhythm problems can prevent sudden death. For the district, this suggests three priorities: testing women born in endemic areas before or during pregnancy, testing their newborns when the mother is positive and making sure blood donors who test positive are referred for evaluation rather than simply notified.
Conclusion
The immune system's partial success against Trypanosoma cruzi is what makes Chagas disease a public health problem: it keeps people well enough to be unaware for decades while the parasite persists. Understanding that biology tells the district whom to find, which test to use and why acting early matters.
References
Bern, C., Kjos, S., Yabsley, M. J., & Montgomery, S. P. (2011). Trypanosoma cruzi and Chagas' disease in the United States. Clinical Microbiology Reviews, 24(4), 655-681. https://doi.org/10.1128/CMR.00005-11
Howard, E., Xiong, X., Carlier, Y., Sosa-Estani, S., & Buekens, P. (2014). Frequency of the congenital transmission of Trypanosoma cruzi: A systematic review and meta-analysis. BJOG: An International Journal of Obstetrics and Gynaecology, 121(1), 22-33. https://doi.org/10.1111/1471-0528.12396
Rassi, A., Jr., Rassi, A., & Marin-Neto, J. A. (2010). Chagas disease. The Lancet, 375(9723), 1388-1402. https://doi.org/10.1016/S0140-6736(10)60061-X
What the PHE 321 Module 3 instructions ask for
The third PHE 321 module calls for a brief APA 7 paper, often three or four pages, on how the host responds to an infection or exposure and how that response shapes the course of disease. Describe the early phase and why it may be missed. Explain how immune defenses control the agent, what traces they leave and why the agent may persist. Describe how damage develops over time in those who become ill, and what is known and unknown about who progresses. Consider special hosts, such as pregnant people or those with weakened immunity. Explain how treatment effectiveness depends on timing. Close by turning the biology into priorities for testing, treatment and outreach. Plain language wins.
How this PHE 321 Module 3 host response short paper example is built
South Texas's district paper follows Trypanosoma cruzi from a mild acute phase, as Rassi and colleagues describe it, to an immune truce that drops parasites below detection but leaves lifelong antibodies. Persistent parasites and inflammation scar the heart and gut in the 30% to 40% Rassi and colleagues report. Special hosts include people on immune-suppressing drugs and pregnant women, with Howard and colleagues' one-in-twenty congenital rate and Bern and colleagues' point that most U.S. infections are in immigrants. Treatment works best early. The PHE 321 paper sets three priorities: testing women from endemic areas, testing their newborns and referring positive donors for evaluation. Biology sets the order of action.
Where the PHE 321 Module 3 rubric puts the points
Graders of the PHE 321 host response paper typically look for an accurate account of the early and later phases, a clear explanation of how immunity controls and marks an infection, the mechanism of later damage stated with appropriate uncertainty, attention to special hosts, the importance of treatment timing and a strong link from biology to public health priorities. Papers that excel explain why a test works in biological terms and use that to justify screening choices. Plain explanations of immunology earn more credit than dense terminology. Correct APA 7 citations, accurate percentages with their sources and a clear structure round out the higher-scoring work.
PHE 321 Module 3 help: the mistakes that cost points
Host response papers in PHE 321 lose points when they describe immunity in general terms unrelated to the disease, confuse acute and chronic phases, present uncertain mechanisms as settled, ignore special hosts or fail to explain what the biology means for testing and treatment. If your disease is a chronic condition such as type 2 diabetes or asthma, or a viral infection such as hepatitis B, send the prompt and the paper will follow that host response in the same way. Course readings on immunity help anchor the explanation. Our PHE 321 host response papers explain each phase plainly and end with who should be found first and why.
Get PHE 321 Module 3 written to your instructions
Tell us the disease behind your PHE 321 Module 3 paper. We will trace its early and chronic phases, how immunity holds and marks the infection, how harm builds, which hosts face special risk and why treatment timing matters, then set public health priorities, usually inside two days and free on a first order. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More PHE 321 papers and related BS Public Health samples
- PHE 321 Module 1 Discussion: Agent, Host and Environment for One Parasite
- PHE 321 Module 2 Agent Biology Short Paper: How Trypanosoma cruzi Moves and Multiplies
- PHE 101 Module 7 Project Two: A Layered Plan to Prevent Entrapment
PHE 321 Module 3 questions, answered
Where can I find a free PHE 321 Module 3 Host Response Short Paper sample?
This page has the complete PHE 321 Module 3 paper, explaining how the immune response to Trypanosoma cruzi leads from a silent infection to heart disease decades later.
Why is chronic Chagas disease diagnosed with antibody tests?
Because after the acute phase parasites in the blood fall below detectable levels, while antibodies the immune system produces remain detectable for life.
How many people with Chagas disease develop heart problems?
A major review estimated that 30% to 40% of infected people in Latin America have or will develop heart disease, digestive disease or both.
Can Chagas disease be treated?
Yes. Benznidazole and nifurtimox can kill the parasite, and treatment is most effective in acute, congenital and childhood infections.
Why does the timing of treatment matter for public health?
Early treatment often cures and prevents later damage, and treating women before pregnancy lowers the chance of infecting their babies.